GBP/USD, GBP/EUR, GBP/JPY, EUR/USD, USD/CNY, DXY
OILEX LD ORD NPV, LLOYDS BANKING GROUP PLC ORD 10P, UK OIL & GAS PLC ORD 0.01P, VAST RESOURCES PLC ORD 0.1P, FRONTERA RESOURCES CORPORATION ORD SHS USD0.00004 (DI), VODAFONE GROUP PLC ORD USD0.20 20/21
FTSE 100, DAX Index, Euro Stoxx 50, S&P 500, Nasdaq Composite, Nikkei 225
Gold, Silver, Crude Oil, Brent Oil, Natural Gas, Bitcoin
BTC/USD, ETH/USD, BCH/USD, XRP/USD, LTC/USD, ETC/USD
US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y
Gold, Brent Oil, Crude Oil, CFDs on Natural Gas, Palladium, Silver
Last post: June 3rd. See chart. Review: Price was approaching the resistance level. Update: Since the last post, price broke above the resistance level but has failed to stay there and has now fallen back below that level. The breakout was a fake breakout. Conclusion: We need price to break the resistance level again and stay above it before looking for ...
Last post: Feb 28th. See chart. Review: Price had broken a resistance level with a strong move to the upside. Update: Price continued to trend higher but is now in a period of consolidation. Conclusion: We will be waiting for a breakout of the resistance of the consolidation zone before considering a trade. Any comments or questions, do not hesitate to leave ...
Prudent Drug Discovery Company Low market cap (appox £13m at time of writing). Issues shares very rarely (last placing nearly four years ago). Has material interest in its work from larger partners (Pharmaxis). Sold interest in LOXL2 programme for £5m to Pharmaxis in December. Pharmaxis continues to fund and develop LOXL2 inhibitors and Synairgen retains interest ...
